67 phenotypes from 3 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Pepddal/Pepddal CBA/J-Pepddal/GrsrJ	abnormal urine homeostasis	J:87005
	darkened coat color	J:143333
	decreased body size	J:87005, J:143333
	decreased oocyte number	J:87005
	irregular coat pigmentation	J:87005
Pepddal/Pepddal involves: C3H/HeJ * C3HeB/FeJ * CBA/J	abnormal testis morphology	J:143333
	brain vacuoles	J:143333
Pepddal/Pepddal involves: C3H/HeJ * CBA/J	abnormal aorta collagen fibril morphology	J:215150
	abnormal cardiac muscle tissue morphology	J:215150
	abnormal heart morphology	J:215150
	abnormal heart septum morphology	J:215150
	abnormal myocardial fiber morphology	J:215150
	abnormal seminiferous tubule morphology	J:143333
	abnormal testis interstitial tissue morphology	J:143333
	abnormal testis morphology	J:143333
	atrioventricular septal defect	J:215150
	brain vacuoles	J:143333
	darkened coat color	J:143333, J:215150
	decreased circulating testosterone level	J:143333
	decreased collagen level	J:215150
	embryonic growth retardation	J:215150
	increased atrioventricular cushion size	J:215150
	increased fetal cardiomyocyte size	J:215150
	myocardium hypertrophy	J:215150
	postnatal lethality, incomplete penetrance	J:215150
	prenatal lethality, incomplete penetrance	J:215150
	small testis	J:143333
	thick interventricular septum	J:215150
	thick ventricular wall	J:215150
	ventricular septal defect	J:215150
Pepddal/Pepddal involves: CAST/EiJ * CBA/J	abnormal agouti pigmentation	J:215150
	darkened coat color	J:215150
	decreased body size	J:143333
	preweaning lethality	J:215150
Pepdtm1a(KOMP)Wtsi/Pepdtm1a(KOMP)Wtsi C57BL/6N-Pepdtm1a(KOMP)Wtsi/Ucd	abnormal bone structure	J:211773
	abnormal cornea morphology	J:211773
	abnormal joint morphology	J:211773
	abnormal retina morphology	J:211773
	decreased bone mineral content	J:211773
	decreased bone mineral density	J:211773
	decreased immature B cell number	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased transitional stage T1 B cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased circulating insulin level	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased leukocyte cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker NK cell number	J:211773
Pepdtm1b(KOMP)Wtsi/Pepdtm1b(KOMP)Wtsi C57BL/6N-Pepdtm1b(KOMP)Wtsi/Ieg	abnormal behavior	J:211773
	abnormal optic disk morphology	J:211773
	abnormal retina morphology	J:211773
	decreased B cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased bone mineral content	J:211773
	decreased CD5-positive Ly6C-positive T cell number	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	decreased follicular B cell number	J:211773
	decreased heart rate	J:211773
	decreased locomotor activity	J:211773
	decreased mean corpuscular volume	J:211773
	decreased vertical activity	J:211773
	enlarged lymph nodes	J:211773
	hyperactivity	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating unsaturated transferrin level	J:211773
	increased thigmotaxis	J:211773
	prolonged RR interval	J:211773
	short tibia	J:211773
	small stomach	J:211773